Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management

Pratik Choudhary, Birthe S Olsen, Ignacio Conget, John B Welsh, Linda Vorrink, John J Shin, Pratik Choudhary, Birthe S Olsen, Ignacio Conget, John B Welsh, Linda Vorrink, John J Shin

Abstract

Background: The MiniMed 640G sensor-augmented insulin pump system (Medtronic, Inc., Northridge, CA) can automatically suspend insulin delivery in advance of predicted hypoglycemia and restart it upon recovery. The aims of this analysis were to determine the rate at which predicted hypoglycemia was avoided with this strategy, as well as to assess user acceptance of the system and its insulin management features.

Subjects and methods: Forty subjects with type 1 diabetes used the system for 4 weeks. We retrospectively evaluated performance of the system, using downloaded pump and sensor data, and evaluated user acceptance via questionnaires.

Results: There were 2,322 suspend before low events (2.1 per subject-day). The mean (± SD) duration of pump suspension events was 56.4 ± 9.6 min, and the mean subsequent sensor glucose (SG) nadir was 71.8 ± 5.2 mg/dL. SG values following 1,930 (83.1%) of the predictive suspensions did not reach the preset low limit. Nadir SG values of ≤50 and ≤60 mg/dL were seen in 207 (8.9%) and 356 (15.3%) of the predictive suspensions, respectively. Blood glucose (BG) and SG values before and during the study were comparable (P > 0.05). The mean absolute relative difference between paired SG and BG values was 10.9 ± 13.8%. Subjects felt confident using the system, agreed that it helped protect them from hypoglycemia, and wished to continue using it.

Conclusions: Automatic insulin pump suspension as implemented in the MiniMed 640G system can help patients avoid hypoglycemia, without significantly increasing hyperglycemia.

Figures

FIG. 1.
FIG. 1.
(A) Mean and SD of sensor glucose trajectories throughout suspend before low events lasting <30, 30 to <90, and ≥90 min. The line at 54 mg/dL (3.0 mmol/L) represents the most commonly used threshold value. (B) Number and proportion of nadir sensor glucose values following suspend before low events that were greater than the preset low limit (white) or were at or below the preset low limit (black).

References

    1. Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224–232
    1. Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA: Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011;34:2023–2025
    1. Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW: Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013;310:1240–1247
    1. Danne T, Tsioli C, Kordonouri O, Blaesig S, Remus K, Roy A, Keenan B, Lee SW, Kaufman FR: The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise. Diabetes Technol Ther 2014;16:338–347
    1. Buckingham B, Chase HP, Dassau E, Cobry E, Clinton P, Gage V, Caswell K, Wilkinson J, Cameron F, Lee H, Bequette BW, Doyle FJ, 3rd: Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care 2010;33:1013–1017
    1. De Bock MI, Dart J, George CE, Abraham M, Cooper M, Paramalingam N, Keenan B, Spital G, Roy A, Davis EA, Jones TW: Performance of a predictive insulin pump suspension algorithm for prevention of overnight hypoglycaemia [abstract]. Diabetes 2014;63:A240–A241
    1. Veeze H, Rasmussen LG, Agrawal P, Zhong A, Arietta A, Kooi N, Liabat S, Shah R, Kaufman F: Real-life performance evaluation of the New Generation Enlite™ glucose sensor in patients with diabetes mellitus. Pediatr Diabetes 2014;15:100.
    1. Abraham M, Davey R, Paramalingam N, Keenan B, Ambler G, Fairchild J, Cameron F, King B, Jones T, Davis E: Prevention of hypoglycaemia with predictive low glucose management system: comparison of hypoglycaemia induction with exercise and subcutaneous bolus [abstract]. Diabetes Technol Ther 2014;16:A43
    1. Maahs DM, Calhoun P, Buckingham BA, Chase HP, Hramiak I, Lum J, Cameron F, Bequette BW, Aye T, Paul T, Slover R, Wadwa RP, Wilson DM, Kollman C, Beck RW: A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care 2014;37:1885–1891
    1. Beck RW, Raghinaru D, Wadwa RP, Chase HP, Maahs DM, Buckingham BA: Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system. Diabetes Care 2014;37:1224–1229

Source: PubMed

3
Suscribir